YTHDF2 and intrahepatic cholangiocarcinoma: Collectively, these observations indicate that YTHDF2 inhibits apoptosis, accelerates the cell cycle and desensitises ICC to cisplatin treatment by downregulating the expression of CDKN1B in an m6A‐dependent manner.